Inside Look at Sola...
Health Care: Drugs
Hospira Inc. (HSP: NYSE)
$33.87 -0.88 | -2.53%
02/09/12 - 11:39 AM ET
918.36K / 2.13M
Vol / Avg. Vol:34.76 / 34.75
Open / Prev. Close:33.71 - 34.76
Today's Range:26.92 - 59.20
52 Wk Range:14.42%
Performance YTD:TheStreet Rating:
Portfolios with HSP
- Portfolio NameUser Type
- Contributor8 Pharma Stocks to Watch
- ProRobert Bruce
- ProRonald Muhlenkamp
- UserFranks
- ContributorTop 20 Stocks With Large In...
- ProJohn Rogers - Ariel Capital...
- ContributorTheStreet Ratings Top-Rated...
- ProOakmark Equity Income I (OA...
- ContributorTop 20 Stocks With Huge Ins...
- UserVegasDC
Latest HSP Headlines from TheStreet
- UBS: 8 Pharma Stocks to Watch 01.20.12 | 12:01 pm
- Analysts' Actions: AEO, NFLX, ARO, YUM, PC 12.01.11 | 09:12 am
- Hospira Stock Hits New 52-Week Low (HSP) 11.29.11 | 04:11 pm
- Hospira's CEO Discusses Q3 2011 Results - Earnings Call Transcript 10.26.11 | 02:10 pm
- Hospira Stock Hits New 52-Week Low (HSP) 10.19.11 | 10:10 am
- Hospira Hits 52-Week Low on Slashed Forecast 10.18.11 | 12:10 pm
- Hospira Stock Gaps Down On Today's Open (HSP) 10.18.11 | 09:10 am
- Hospira Inc. (HSP): Today's Featured Health Care Loser 10.13.11 | 05:10 pm
- Hospira Inc. Stock Downgraded (HSP) 09.29.11 | 07:09 am
- Hewlett-Packard, Texan: Analysts' New Ratings 08.17.11 | 09:08 am
Press Releases for HSP
- Hospira Names Richard Davies Chief Commercial Officer - PR Newswire 01.30.12 | 04:01 pm
- Hospira To Host Conference Call For Fourth-Quarter 2011 Results And 2012 Projections - PR Newswire 01.16.12 | 03:01 pm
- Hospira Announces Start Of U.S. Phase III Biosimilar EPO Clinical Program - PR Newswire 01.09.12 | 03:01 pm
- Harwood Feffer LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against Hospira Inc. - Business Wire 12.27.11 | 03:12 pm
- Hospira To Host Conference Call For Fourth-Quarter 2011 Results And 2012 Projections - PR Newswire 12.22.11 | 02:12 pm
- Hospira To Present At The J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012 - PR Newswire 12.14.11 | 03:12 pm
- Hospira Board Announces Retirement Of Executive Chairman And Former CEO Christopher B. Begley; Names John C. Staley Chairman - PR Newswire 12.07.11 | 04:12 pm
- The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In Hospira, Inc. Of Class Action Lawsuit And The Deadline Of January 20, 2012 To Seek A Lead Plaintiff Position - PR Newswire 11.30.11 | 03:11 pm
- Faruqi & Faruqi, LLP Announces Investigation Of Hospira, Inc. - Business Wire 11.23.11 | 07:11 pm
- Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Hospira, Inc. - Business Wire 11.21.11 | 06:11 pm
Partner Headlines for HSP
- Biosimilars: The Next Big Thing - Analyst Blog - Zacks 01.13.12 | 05:01 pm
- ETF Showdown: Fun With Pharma - Benzinga 12.30.11 | 04:12 pm
- Covidien, Abbott Setting A Spin-Out Trend - Seeking Alpha 12.18.11 | 09:12 am
- Top Stock Picks From John Rogers - Seeking Alpha 12.01.11 | 08:12 am
- Hospira Still at Underperform - Analyst Blog - Zacks 11.11.11 | 06:11 pm
- Hospira, Inc. (HSP) - Bear of the Day - Zacks 11.10.11 | 01:11 am
- Hospira, Inc. (HSP) - Bear of the Day - Zacks 11.03.11 | 01:11 am
- Hospira, Inc. (HSP) - Bear of the Day - Zacks 10.27.11 | 01:10 am
- Hearing Hospira Downgraded to Neutral at Ticonderoga - Benzinga 10.18.11 | 01:10 pm
- CORRECTED - Hospira looks to M&A to penetrate emerging markets - Reuters 09.07.11 | 11:09 am
